Metrics as of 10/15/2026, 02:18 PM (Berlin time), refresh in progress.
Pharming Group Stock
Pharming Group N.V.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Netherlands
- CEO
- Fabrice Chouraqui
- Employees
- 407
- Market cap
- $682 M
- IPO
- 23/12/2020
Pharming Group N.V. is a biopharmaceutical company dedicated to the creation and commercialization of protein replacement therapies and precision medicines. The firm concentrates its efforts on addressing rare diseases and critical unmet medical needs across the United States, Europe, and other international markets.…
Pharming Group stock: price history
1D
+2.1%
1W
-0.1%
1M
-10.9%
6M
-45.8%
YTD
-45.4%
1Y
-33.7%
2Y
+13.3%
5Y
+2.1%
10Y
–
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~53% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 16/10/26. Not a buy or sell signal.Beta
What does this mean?
Double top
BearishThe price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Pharming Group
Analyst assessment of Pharming Group
PRICE TARGET LOW
US$38.00
CONSENSUS
US$39.00
MEDIAN
US$39.00
PRICE TARGET HIGH
US$40.00
0
STRONG BUY
3
BUY
0
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Buy
As of: 22/09/2026
Pharming Group stock metrics
P/E
64.61
P/B
2.62
EV/EBITDA
17.95
RETURN ON EQUITY
0.6%
NET MARGIN
1.8%
DEBT/EQUITY
0.42
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
98.4%
FLOAT SHARES
69,656,999
AVG. DAILY VOLUME (30D)
27,265
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +2.1%
Forums (Reddit)
Institutional holders
Comparable stocks
Frequently asked questions about Pharming Group stock
What does Pharming Group do?
Pharming Group N.V. is a company in the Healthcare sector, Biotechnology industry, headquartered in Netherlands.
The CEO is Fabrice Chouraqui, the company employs around 407 people.
The IPO was on 23/12/2020; the stock trades on NASDAQ under the ticker PHAR.
What do analysts say about Pharming Group stock?
3 analysts rate the stock, the consensus is Buy (as of 22/09/2026).
The average price target is US$39.00, ranging from US$38.00 to US$40.00, with a median of US$39.00.
This is an external assessment, not a statement by Market Jury.
When does Pharming Group report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 53% stronger than usual.
Does Pharming Group pay a dividend?
No, Pharming Group currently does not pay a dividend.
Which stocks are comparable to Pharming Group?
Comparable stocks include argenx, Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, BeOne Medicines, Incyte and Genmab A/S.
How can I get Pharming Group stock analyzed?
Clicking "Analyze stock" lets five strategies assess Pharming Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.